Admedus Ltd, Product Pipeline Analysis - Updated 2019 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Feb 14, 2020--
The “Admedus Ltd (AHZ) - Product Pipeline Analysis, 2019 Update” company profile has been added to ResearchAndMarkets.com’s offering.
Admedus Ltd (Admedus) develops, manufactures and distributes medical devices and technologies with focus on tissue engineering and immunotherapies. Using its proprietary ADAPT engineering process, the company is developing a group of regenerative tissue bio-scaffolds for use in soft tissue repairs. Its flagship product, CardioCel is a regenerative tissue for cardiac repairs and reconstructions. The company also distributes infusion systems including ambulatory pumps, syringe and volumetric pumps, administration accessories, Amnicot finger cot, nasal spray (PCA) device and O’Neil urinary catheters. Admedus is developing next generation vaccines for the treatment and prevention of infectious diseases and cancers with an initial focus on Herpes Simplex Virus (HSV-2) and Human papillomavirus (HPV). Admedus is headquartered in Malaga, Western Australia, Australia.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Reasons to Buy:
Key Topics Covered:
For more information about this company profile visit https://www.researchandmarkets.com/r/dmf6su
View source version on businesswire.com:https://www.businesswire.com/news/home/20200214005253/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: MEDICAL DEVICES HEALTH
SOURCE: Research and Markets
Copyright Business Wire 2020.
PUB: 02/14/2020 08:09 AM/DISC: 02/14/2020 08:08 AM